What are your options there
Tirzepatide, also known as Zepbound, is an FDA-approved dual GLP-1/GIP receptor agonist, and it's changing lives with its effectiveness in weight loss
According to the Summary of Product Characteristics (SmPC), semaglutide undergoes metabolism in the liver with metabolites excreted via urine and faeces in roughly equal proportions, with minimal unchanged renal excretion
Clinical trials show that 6070% of semaglutide patients experience reduced cravings for sweet foods within the first month
At the moment, Mounjaro is a diabetes drug, but Pisano said that the FDA is currently examining data on whether to include it in the weight loss class, and that decision might come in October
Note, however, that many symptoms of iron deficiency , such as tiredness or weakness, resemble fibromyalgia symptoms